6-116877441-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_173560.4(RFX6):c.166G>T(p.Glu56Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000697 in 1,434,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_173560.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RFX6 | NM_173560.4 | c.166G>T | p.Glu56Ter | stop_gained | 1/19 | ENST00000332958.3 | |
RFX6 | XM_011535589.2 | c.166G>T | p.Glu56Ter | stop_gained | 1/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RFX6 | ENST00000332958.3 | c.166G>T | p.Glu56Ter | stop_gained | 1/19 | 1 | NM_173560.4 | P1 | |
RFX6 | ENST00000487683.5 | n.230G>T | non_coding_transcript_exon_variant | 1/14 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.97e-7 AC: 1AN: 1434572Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 710630
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maturity onset diabetes mellitus in young Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Mar 03, 2022 | This sequence change in RFX6 is a nonsense variant predicted to cause a premature stop codon, p.(Glu56*), in biologically-relevant-exon 1/19 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PMID: 29026101, 31001871). This variant is absent from gnomAD v2.1 and v3.1. To our knowledge, this variant has not been reported in the literature in any individuals with RFX6-related disease. Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PVS1, PM2_Supporting. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at